Kisspeptin-10
Published · Researched 2026-09-21
Category: Libido, Tanning, Sleep & Niche · Research date: 2026-09-20 · Slug: kisspeptin-10
Overview
Kisspeptin-10 (KP-10, metastin 45–54) is a synthetic decapeptide fragment of the kisspeptin family — the upstream neuropeptide signal that drives hypothalamic GnRH release and, downstream of that, LH/FSH and sex-steroid production. In 2026 it circulates in biohacking and libido-peptide circles as a research compound discussed for low motivation, low libido, and hormonal-axis signaling, most often sold as 5 mg lyophilized vials from research-peptide vendors. The single most repeated community criticism is its very short half-life, which skeptics cite as the reason KP-10 never became a practical therapeutic despite real upstream biology. It is frequently name-paired with PT-141 in women's libido discussions.
Social standing
Threads: Direct owner signal is thin but present. A May 31, 2026 thread had a user asking whether any women had started Kisspeptin — a genuine newcomer/experience-seeking question that drew engagement. @privintel (TheBioArchitect, 2026-07-03) discussed PT-141 alongside kisspeptin for female HSDD after GLP-1/weight-loss, a pairing framing echoed across women's-health threads. Otherwise the peptide shows up mostly as generic supplier chatter rather than experience reports.
Instagram: The liveliest layer, but ad-heavy. @brendanpaul.a (2026-07-14) promoted Kisspeptin alongside retatrutide for low motivation/libido; comments were mixed — sourcing and dosing requests alongside open skepticism about Kisspeptin-10's short half-life. @rachelokinsfit (2026-07-15) covered the same trend. This is biohacker-influencer content, not neutral medical consensus, and should be read as marketing-adjacent.
Facebook: No verified item-level discussion was found in the surveyed groups (Peptides – information. Education. and sharing (1,000 members), Peptide Community 101 (878), Biohacking, Longevity, CRISPR, Supplements, Life Extension, Wim Hof (10,000)) — direct Kisspeptin queries returned zero posts. This is the main reason the item does not reach Tier 1.
Recurring praise: upstream mechanism (acts at the top of the reproductive axis rather than downstream); interest for libido/motivation, especially in women post-weight-loss.
Recurring complaints: short half-life makes it impractical (the dominant criticism); sourcing/dosing questions dominate over actual experience reports; much of the visible content is influencer promotion rather than owner evidence.
Social validation
Tier: Tier 2 — genuine social signal on Instagram and Threads, but no verified Facebook-group item discussion and a heavy ad/influencer skew.
Named sources and what each proves:
- Instagram @brendanpaul.a (2026-07-14) — proves Kisspeptin's 2026 biohacking-trend status (paired with retatrutide for motivation/libido) and documents the community's half-life skepticism in comments.
- Instagram @rachelokinsfit (2026-07-15) — proves the same trend was being pushed by multiple fitness creators simultaneously (coordinated-hype signal, not independent evidence).
- Threads @privintel (2026-07-03) — proves the PT-141 + kisspeptin pairing frame in women's HSDD discussion.
- Threads (2026-05-31 user thread) — proves genuine newcomer curiosity ("have any women started Kisspeptin?") rather than vendor-seeded content.
Key specs table
| Spec | Detail |
|---|---|
| Identity | Kisspeptin-10 (KP-10), metastin fragment 45–54, synthetic decapeptide |
| Sequence | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (as catalog-listed by vendors) |
| Formula / MW | C63H83N17O14 · ~1302.5 g/mol · CAS 374675-21-5 (as catalog-listed; primary-source verification not performed) |
| Target | KISS1R (GPR54) — upstream of hypothalamic GnRH release |
| Vial sizes (grey market) | 5 mg lyophilized per vial (standard) |
| Half-life | Frequently described as minutes-scale in community/vendor copy — UNVERIFIED; no primary pharmacokinetic source confirmed in this pass |
| Community-reported research use | Sourcing and dosing questions dominate discussion; no verified community dosing consensus was observed in this pass. Reported behavior only — not instructions. |
| Storage | Lyophilized: −20 °C long-term (vendors also state RT stable ~90 days); reconstituted: 2–8 °C, short use window; avoid freeze–thaw |
Pricing
All prices observed 2026-09-20 from research-peptide vendor listings (grey market, research-use-only), 5 mg vials unless noted.
| Vendor / source | Price | Notes |
|---|---|---|
| CoreVionRX | $75 (5 mg) | single-vial listing |
| Market dataset (multi-vendor) | median $6.65/mg, high $9.60/mg | ≈ $33–$48 per 5 mg at median; one obvious anomalous/outlier row excluded as untrustworthy |
| Cayman/Biomol (reagent grade) | €87 (1 mg) / €359 (5 mg) / €549 (10 mg) | lab-reagent pricing, not grey-market street pricing |
- Street range: roughly $33–$75 per 5 mg vial depending on vendor tier.
- Facebook Marketplace: not searched in this pass — used-value range UNVERIFIED.
- Exact stock/availability at time of writing: UNVERIFIED.
What's included / what's needed
Vial listings ship the lyophilized 5 mg vial only (some vendors add a per-lot COA). Needed separately per community practice: bacteriostatic water, insulin syringes for subcutaneous use. No kit-style bundles were observed as standard for this item.
Support reality
No manufacturer warranty exists on research vials; vendor satisfaction guarantees (where advertised) are vendor policies, not enforceable warranties, with mixed community reporting on honoring. No independent certification body exists — per-lot third-party COAs are the community's only quality instrument, and the standing advice is to demand them. Ad-heavy influencer promotion around Kisspeptin in 2026 shows weak organic interest relative to its hype volume — treat influencer-driven visibility as a negative reliability signal, not validation.
Community verdict
Kisspeptin-10 has real upstream biology and genuine curiosity behind it — especially the PT-141 pairing frame for women's libido — but the community's dominant note is skepticism: the short half-life criticism appears in nearly every serious discussion, experience reports are scarce relative to promotional content, and no Facebook-group dosing culture was observed. It reads as a trend ingredient rather than a community-validated staple.
Regulatory & safety status
- No FDA or EMA approval for kisspeptin-10 for any human use. It is a research compound; this status was consistent across all sources checked.
- Human kisspeptin research exists in academic/clinical-trial settings (reproductive endocrinology), but that does not transfer to grey-market vials in any form.
- Safety profile in self-administered use: UNVERIFIED — no reliable community adverse-event consensus was observed; absence of reports is not evidence of safety.
Image views
6 of 8 views obtained (vendor product images, JPEG). The "top-angle" and "real-owner-in-use" views were unavailable; no verifiable real-owner product photos of Kisspeptin-10 vials were found.
- hero:
img/kisspeptin-10-hero.jpg - side-profile:
img/kisspeptin-10-side-profile.jpg - rear:
img/kisspeptin-10-rear.jpg - detail:
img/kisspeptin-10-detail.jpg - scale:
img/kisspeptin-10-scale.jpg - box-accessories:
img/kisspeptin-10-box-accessories.jpg - top-angle: unavailable — no distinct top-view vendor image found
- real-owner-in-use: unavailable — no verifiable real-owner product photos found
Not medical advice. This is research documentation only. Kisspeptin-10 is an unapproved research compound; consult a licensed healthcare provider.
Named sources
- Instagram @brendanpaul.a (2026-07-14) — proves Kisspeptin's 2026 biohacking-trend status (paired with retatrutide for motivation/libido) and documents the community's half-life skepticism in comments. (2026-07-14)
- Instagram @rachelokinsfit (2026-07-15) — proves the same trend was being pushed by multiple fitness creators simultaneously (coordinated-hype signal, not independent evidence). (2026-07-15)
- Threads @privintel (2026-07-03) — proves the PT-141 + kisspeptin pairing frame in women's HSDD discussion. (2026-07-03)
- Threads (2026-05-31 user thread) — proves genuine newcomer curiosity ("have any women started Kisspeptin?") rather than vendor-seeded content. (2026-05-31)
Source URLs were not recorded for these references.